Seeking Alpha·Oct 28, 2026
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call TranscriptLabcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Labcorp's revenue grew 6.9% year over year to $3.8B in Q3 2026, and gross margin recovered from 26.2% in Q4 2025 to 29.1%, suggesting steady underlying demand across its diagnostics base.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue reached $3.8B with a 6.9% net margin in Q3 2026, but operating margin compressed to 10.6% from 12.1% in the prior quarter, suggesting margin recovery remains fragile.
Labcorp's collaboration with AWS and Datavant has created an AI-driven platform that leverages longitudinal laboratory data and advanced analytics to accelerate drug discovery and streamline processes.
Labcorp provides end-to-end drug development and clinical laboratory services, positioning it as a leader in guiding patient care and life sciences innovation.
The company has a strong legacy in genomic testing, including early adoption of PCR technology, enhancing its credibility and capabilities in molecular biology and pathology.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 28, 2026 | $4.78+3.0% vs $4.64 | $3.8B+1.4% vs $3.8B |
Q3 2026 Jul 30, 2026 | $4.99+4.4% vs $4.78 | $3.7B+0.6% vs $3.7B |
Q2 2026 Apr 30, 2026 | $4.25+3.4% vs $4.11 | $3.5B+0.8% vs $3.5B |
Q1 2026 Feb 17, 2026 | $4.07+3.0% vs $3.95 | $3.5B-1.2% vs $3.6B |
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook.
Labcorp NYSE: LH reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenue and earnings outlook.
Labcorp shares rise as Q3 earnings and revenues beat estimates, both segments deliver growth, margins expand and the company raises its 2026 financial outlook.
Benchmark LH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Labcorp Holdings Inc. (LH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $366.57 | $30.06B | 29.79 | 7.25% | 6.88% | 11.52% | 0.78% | |
| $255.63 | $28.21B | 25.36 | 11.78% | 9.53% | 14.66% | 1.22% | |
| $381.57 | $10.27B | 10.05 | 0.65% | 39.45% | 14.07% | — | |
| $310.67 | $44.49B | -271.73 | 35.9% | -5.66% | -9.18% | — | |
| $271.83 | $44.74B | 32.57 | 5.87% | 8.05% | 21.39% | — | |
| $337.52 | $16.26B | 408.03 | -0.85% | 1.01% | 1.3% | — |
Labcorp Holdings Inc. (LH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Labcorp Holdings Inc. (LH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 28, 2026·SEC
Oct 21, 2026·SEC
Sep 30, 2026·SEC
Get notified when LH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Labcorp Holdings Inc. (LH) stock FAQ — growth, dividends, profitability & financials explained
Labcorp Holdings Inc. (LH) reported $14.59B in revenue over the trailing twelve months. Revenue was $13.95B in fiscal year 2025. That is 768% more than the $1.61B of fiscal year 1996.
Labcorp Holdings Inc. (LH) grew revenue by 6.0% over the trailing twelve months, compared with the twelve months before.
Yes. Labcorp Holdings Inc. (LH) earned $1.00B in net income over the trailing twelve months (a 6.9% net margin).
Yes. Labcorp Holdings Inc. (LH) pays a dividend that yields 0.78% at the current price, a small yield.
Labcorp Holdings Inc. (LH) had a return on equity (ROE) of 11.5% over the trailing twelve months. That is in line with the market's typical 10-15%.
Labcorp Holdings Inc. (LH) generated $1.29B in free cash flow over the trailing twelve months.
